Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157524 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaolin Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Center of Excellence, Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA 70112, …. Hauptthemen laut MEDLINE: tau Proteins, Cognitive Dysfunction, Tauopathies. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH/NINDS, LIFT.
Abstract (Originalsprache)
Using the fly eye as a model system, we previously demonstrated that upregulation of the fly gene mask protects against FUS- and Tau-induced photoreceptor degeneration. Building upon this finding, we investigated whether the protective role of mask is conserved in mammals. To this end, we generated a transgenic mouse line carrying Cre-inducible ANKHD1, the human homolog of mask. Utilizing the TauP301S-PS19 mouse model for Tau-related dementia, we found that expressing ANKHD1 driven by CamK2a-Cre reduced hyperphosphorylated human Tau in 6-month-old mice. Additionally, ANKHD1 expression was associated with a trend toward reduced gliosis and preservation of the presynaptic marker Synaptophysin, suggesting a protective role of ANKHD1 against TauP301S-linked neuropathology. At 9 months of age, novel object recognition (NOR) testing revealed cognitive impairment in female, but not male, PS19 mice. Notably, co-expression of ANKHD1 restored cognitive performance in the affected female mice. Together, this study highlights the novel effect of ANKHD1 in counteracting the adverse effects induced by the mutant human Tau protein. This finding underscores ANKHD1’s potential as a unique therapeutic target for tauopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Center of Excellence, Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
- Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA 70112, USA.
- LSU Health Shreveport, School of Medicine, 1501 Kings Highway, Shreveport, LA 71103, USA.
ORCID-Profile: Xiaolin Tian, Chunlai Wu
Förderung
- NINDS NIH HHS
- NIH/NINDS
- LIFT
Zitieren
APA
Tian, X., Le, N., Zhao, Y., Alawamleh, D., Schwartz, A., Meyer, L., Helm, E., & Wu, C. (2025). Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157524
Vancouver
Tian X, Le N, Zhao Y, Alawamleh D, Schwartz A, Meyer L, et al. Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157524
BibTeX
@article{Tian2025,
author = {Tian, Xiaolin and Le, Nathan and Zhao, Yuhai and Alawamleh, Dina and Schwartz, Andrew and Meyer, Lauren and Helm, Elizabeth and Wu, Chunlai},
title = {Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157524}
}
EUVIMED